Immune-related generalised oedema – A new category of adverse events with immune checkpoint inhibitors
Maud Velev, Barouyr Baroudjian, Roxane Pruvost, Eléonora De Martin, Ariane Laparra, Samy Babai, Sandra Teysseire, François‐Xavier Danlos, Laurence Albigès, Charlotte Bernigaud, Marc‐Antoine Benderra, Pauline Pradère, Mohamad Zaidan, C. Decroisette, Fatma Fallah, Gaelle Matergia, Pernelle Lavaud, Hélène Jantzem, Marina Atzenhoffer, Véronique Buyse, Samy Ammari, Caroline Robert, Stéphane Champiat, Sabine Messayke, Aurélien Marabelle, Catherine Guettier, Célèste Lebbé, Olivier Lambotte, Jean‐Marie Michot
Topics & Concepts
MedicineNivolumabPembrolizumabProspective cohort studyInternal medicineAdverse effectPharmacovigilanceIpilimumabPathologicalImmune systemGastroenterologyCancerImmunotherapyImmunologyCancer Immunotherapy and BiomarkersMultiple Myeloma Research and TreatmentsProstate Cancer Treatment and Research